PartsTable TECHNICAL DATA SHEET
NSN 6505-01-285-0171Government record, cited

Labetalol Hydrochloride Injectio6505-01-285-0171

NSN 6505-01-285-0171 · NIIN 012850171
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-285-0171 · 6505012850171 · NIIN 012850171 · 01-285-0171 · FSC 6505 Drugs and Biologicals · NORMODYNE INJECTION · NDC00173-0350-00 · TRANDATE INJECTION · NDC00085-0362-08 · NORMODYNE
Nearby stock numbers  ·
Features
  • Labetalol Hydrochloride Injectio — FSC 6505
  • Primary Container Content Quantity: 4.000 MILLILITERS
  • Medical Designation and Grade: UNITED STATES PHARMACOPEIA
  • Primary Container Type: SYRINGE-NEEDLE UNIT
  • Active Medicament Medicinal Strength: 5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER
Identification
  • NSN: 6505-01-285-0171
  • NIIN: 012850171
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Labetalol Hydrochloride Injectio, cataloged under National Stock Number 6505-01-285-0171, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 6 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.

Technical Specifications
ParameterValue
NSN6505-01-285-0171
Item NameLabetalol Hydrochloride Injectio
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
Primary Container Content Quantity4.000 MILLILITERS
Medical Designation and GradeUNITED STATES PHARMACOPEIA
Primary Container TypeSYRINGE-NEEDLE UNIT
Active Medicament Medicinal Strength5.000 MILLIGRAMS LABETALOL HYDROCHLORIDE PER MILLILITER
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardHazardous per DLA record (HMIC Y)
Criticality CodeX
Unit of IssueEA
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
NORMODYNE INJECTION 5/9 Secondary reference
Schering-Plough Corporation
NDC00173-0350-00 5/9 Secondary reference
Glaxo Wellcome Inc
TRANDATE INJECTION 5/1 Secondary reference
Glaxo Wellcome Inc
NDC00085-0362-08 3/9 Design control — primary reference
Schering-Plough Corporation
NORMODYNE 5/9 Secondary reference
Schering-Plough Corporation
TRANDATE 5/1 Secondary reference
Glaxo Wellcome Inc

Frequently Asked Questions

What is NSN 6505-01-285-0171?

NSN 6505-01-285-0171 is a Labetalol Hydrochloride Injectio, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-285-0171?

Key specifications for 6505-01-285-0171: Primary Container Content Quantity: 4.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: SYRINGE-NEEDLE UNIT; Special Features: SINGLE DOSE; PREFILLED; DISPOSABLE SYRINGE. 4 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-285-0171 hazardous material?

Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com